Robert Jobe

1.2k total citations
21 papers, 616 citations indexed

About

Robert Jobe is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Jobe has authored 21 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Jobe's work include Coronary Interventions and Diagnostics (11 papers), Vascular Procedures and Complications (7 papers) and Cardiac Valve Diseases and Treatments (5 papers). Robert Jobe is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Vascular Procedures and Complications (7 papers) and Cardiac Valve Diseases and Treatments (5 papers). Robert Jobe collaborates with scholars based in United States, Belgium and Japan. Robert Jobe's co-authors include D. E. Hansen, L. Katherine Taylor, Ian T. Meredith, Stephan Windecker, Dean J. Kereiakes, Shamir R. Mehta, Joel E. Schneider, Christophe Dubois, Shigeru Saito and Timothy P. Grady and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Robert Jobe

19 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Jobe United States	11	396	379	289	97	83	21	616
Takaaki Shiono Japan	11	178 0.4×	200 0.5×	199 0.7×	42 0.4×	67 0.8×	22	391
Micheal A. Kuhn United States	15	212 0.5×	338 0.9×	153 0.5×	22 0.2×	23 0.3×	34	586
T J Fogarty United States	6	140 0.4×	413 1.1×	452 1.6×	20 0.2×	14 0.2×	9	587
Simon Eccleshall United Kingdom	14	530 1.3×	623 1.6×	282 1.0×	65 0.7×	77 0.9×	53	810
Marco Sesana Italy	11	285 0.7×	250 0.7×	131 0.5×	60 0.6×	26 0.3×	30	405
G. Mommertz Germany	11	148 0.4×	159 0.4×	308 1.1×	25 0.3×	31 0.4×	23	412
S Amikam Israel	12	261 0.7×	167 0.4×	84 0.3×	6 0.1×	11 0.1×	37	415
Makram R. Ebeid United States	12	167 0.4×	200 0.5×	228 0.8×	6 0.1×	12 0.1×	32	484
Neil Swanson United Kingdom	8	161 0.4×	164 0.4×	122 0.4×	42 0.4×	21 0.3×	24	313
Emanuel R. Reinitz United States	9	34 0.1×	213 0.6×	227 0.8×	23 0.2×	190 2.3×	12	366

Countries citing papers authored by Robert Jobe

Since Specialization

Citations

This map shows the geographic impact of Robert Jobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Jobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Jobe more than expected).

Fields of papers citing papers by Robert Jobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Jobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Jobe. The network helps show where Robert Jobe may publish in the future.

Co-authorship network of co-authors of Robert Jobe

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Jobe. A scholar is included among the top collaborators of Robert Jobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Jobe. Robert Jobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kereiakes, Dean J., Stephan Windecker, Robert Jobe, et al.. (2019). FINAL 5-YEAR OUTCOMES OF THE EVOLVE II TRIAL: A PROSPECTIVE RANDOMIZED INVESTIGATION OF A NOVEL BIOABSORBABLE POLYMER-COATED, EVEROLIMUS-ELUTING SYNERGY STENT. Journal of the American College of Cardiology. 73(9). 1029–1029. 1 indexed citations

2.

Kereiakes, Dean J., Stephan Windecker, Robert Jobe, et al.. (2019). Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents. Circulation Cardiovascular Interventions. 12(9). e008152–e008152. 41 indexed citations

3.

Mehran, Roxana, Michela Faggioni, Jaya Chandrasekhar, et al.. (2018). Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography. JACC: Cardiovascular Interventions. 11(16). 1601–1610. 34 indexed citations

4.

Jobe, Robert, Stephan Windecker, David M. Mego, et al.. (2018). CLINICAL OUTCOMES TO 4 YEARS IN PATIENTS IMPLANTED WITH BIOABSORBABLE POLYMER SYNERGY VERSUS PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: THE EVOLVE II RANDOMIZED TRIAL. Journal of the American College of Cardiology. 71(11). A1018–A1018. 3 indexed citations

5.

Aminian, Adel, Shigeru Saito, Akihiko Takahashi, et al.. (2018). Impact of sheath size and hemostasis time on radial artery patency after transradial coronary angiography and intervention in Japanese and non‐Japanese patients: A substudy from RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT) randomized multicenter trial. Catheterization and Cardiovascular Interventions. 92(5). 844–851. 39 indexed citations

6.

Kereiakes, Dean J., Ian T. Meredith, Mónica Masotti, et al.. (2017). Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy. EuroIntervention. 12(16). 1987–1994. 14 indexed citations

7.

Aminian, Adel, Shigeru Saito, Akihiko Takahashi, et al.. (2017). Comparison of a new slender 6 Fr sheath with a standard 5 Fr sheath for transradial coronary angiography and intervention: RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT), a randomised multicentre trial. EuroIntervention. 13(5). e549–e556. 47 indexed citations

8.

Kereiakes, Dean J., Ian T. Meredith, Stephan Windecker, et al.. (2015). Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent. Circulation Cardiovascular Interventions. 8(4). 174 indexed citations

9.

Kereiakes, Dean J., Ian T. Meredith, Stephan Windecker, et al.. (2014). Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent. Circulation. 130(23). 2111–2111. 3 indexed citations

10.

Jobe, Robert & Tift Mann. (2009). Transradial consensus statement: appropriateness ratings for patient selection and physicians' performing procedures.. PubMed. 107(9). 587–8.

11.

Wood, Frances O., et al.. (2008). Unprotected left main disease managed with drug‐eluting stents: Long‐term outcome of 100 patients with increased surgical risk. Catheterization and Cardiovascular Interventions. 71(4). 533–538. 12 indexed citations

12.

Wood, Frances O., et al.. (2005). Technique of left main stenting is dependent on lesion location and distal branch protection. Catheterization and Cardiovascular Interventions. 65(4). 499–503. 18 indexed citations

13.

Mann, Tift, Roberto J. Cubeddu, Josie Bowen, et al.. (2003). Coronary stenting in stable patients: Identification of a low‐risk subgroup that may not require adjunctive antiplatelet therapy. Catheterization and Cardiovascular Interventions. 58(4). 459–466. 3 indexed citations

14.

Mann, Tift, Patricia A. Cowper, Eric D. Peterson, et al.. (2000). Transradial coronary stenting: Comparison with femoral access closed with an arterial suture device. Catheterization and Cardiovascular Interventions. 49(2). 150–156. 111 indexed citations

15.

Mann, Tift, Patricia A. Cowper, Eric D. Peterson, et al.. (2000). Transradial coronary stenting: Comparison with femoral access closed with an arterial suture device. Catheterization and Cardiovascular Interventions. 49(2). 150–150. 11 indexed citations

16.

Jobe, Robert, et al.. (1994). Effect of ryanodine on the initiation and perpetuation of stretch-induced arrhythmias in isolated canine ventricle. American Journal of Physiology-Heart and Circulatory Physiology. 267(5). H1736–H1744. 2 indexed citations

17.

Jobe, Robert & Mervyn B. Forman. (1993). Focal Pulmonary Embolism Presenting as Diffuse Pulmonary Edema. CHEST Journal. 103(2). 644–646. 4 indexed citations

18.

Jobe, Robert, et al.. (1992). Stretch-induced depolarizations as a trigger of arrhythmias in isolated canine left ventricles. American Journal of Physiology-Heart and Circulatory Physiology. 263(2). H613–H621. 84 indexed citations

19.

Jobe, Robert & John J. Gallagher. (1991). Use of adenosine during hypotension in the Wolff-Parkinson-White syndrome with supraventricular tachycardia. American Heart Journal. 121(4). 1239–1240. 7 indexed citations

20.

Jobe, Robert, et al.. (1968). MARKING THE SURGICAL SPECIMEN IN SKIN NEOPLASM EXCISION. Plastic & Reconstructive Surgery. 42(6). 611–611.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact